Transcutaneous osseointegration for amputees with burn trauma.


Journal

Burns : journal of the International Society for Burn Injuries
ISSN: 1879-1409
Titre abrégé: Burns
Pays: Netherlands
ID NLM: 8913178

Informations de publication

Date de publication:
08 2023
Historique:
received: 09 11 2022
revised: 14 02 2023
accepted: 19 02 2023
medline: 12 6 2023
pubmed: 13 3 2023
entrez: 12 3 2023
Statut: ppublish

Résumé

Transcutaneous osseointegration for amputees (TOFA) surgically implants a prosthetic anchor into the residual limb's bone, enabling direct skeletal connection to a prosthetic limb and eliminating the socket. TOFA has demonstrated significant mobility and quality of life benefits for most amputees, but concerns regarding its safety for patients with burned skin have limited its use. This is the first report of the use of TOFA for burned amputees. Retrospective chart review was performed of five patients (eight limbs) with a history of burn trauma and subsequent osseointegration. The primary outcome was adverse events such as infection and additional surgery. Secondary outcomes included mobility and quality of life changes. The five patients (eight limbs) had an average follow-up time of 3.8 ± 1.7 (range 2.1-6.6) years. We found no issues of skin compatibility or pain associated with the TOFA implant. Three patients underwent subsequent surgical debridement, one of whom had both implants removed and eventually reimplanted. K-level mobility improved (K2 +, 0/5 vs 4/5). Other mobility and quality of life outcomes comparisons are limited by available data. TOFA is safe and compatible for amputees with a history of burn trauma. Rehabilitation capacity is influenced more by the patient's overall medical and physical capacity than their specific burn injury. Judicious use of TOFA for appropriately selected burn amputees seems safe and merited.

Identifiants

pubmed: 36907716
pii: S0305-4179(23)00034-7
doi: 10.1016/j.burns.2023.02.006
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1052-1061

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Competing interests Munjed Al Muderis is the sole beneficiary of Osseointegration Holdings Pty Ltd (“OH”) and Osseointegration International Pty Ltd (“OI”). OI exclusively distributes the OPL implant system worldwide. OH owns the rights and patents to the OPL implant system. All other authors declare no competing interests.

Auteurs

Amanullah Haidary (A)

Western Sydney University School of Medicine, Building 30 Campbelltown Campus, Campbelltown, NSW, Australia. Electronic address: haidary.aman@gmail.com.

Jason S Hoellwarth (JS)

Limb Lengthening and Complex Reconstruction Service, Osseointegration Limb Replacement Center, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USA. Electronic address: drjsoon@gmail.com.

Kevin Tetsworth (K)

Department of Orthopaedic Surgery, Royal Brisbane and Women's Hospital, Queensland, Australia. Electronic address: ktetsworthmd@gmail.com.

Atiya Oomatia (A)

Limb Reconstruction Centre, Macquarie University Hospital, Macquarie University, Macquarie Park, Australia. Electronic address: tiya@osseointegrationaustralia.com.au.

Munjed Al Muderis (M)

Limb Reconstruction Centre, Macquarie University Hospital, Macquarie University, Macquarie Park, Australia. Electronic address: munjed@almuderis.com.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH